Letter to the Editor Regarding "Colchicine Against SARS-CoV-2 Infection: What is the Evidence?".
作者信息
Finsterer Josef
机构信息
Neurology and Neurophysiology Center, Postfach 20, 1180, Vienna, Austria.
出版信息
Rheumatol Ther. 2022 Aug;9(4):1229-1231. doi: 10.1007/s40744-022-00456-7. Epub 2022 Jun 13.
Abstract
摘要
相似文献
1
Letter to the Editor Regarding "Colchicine Against SARS-CoV-2 Infection: What is the Evidence?".致编辑的信：关于“秋水仙碱抗新型冠状病毒感染：证据何在？”
Rheumatol Ther. 2022 Aug;9(4):1229-1231. doi: 10.1007/s40744-022-00456-7. Epub 2022 Jun 13.
2
A Response to: Letter to the Editor Regarding the Article: "Colchicine Against SARS-CoV-2 Infection: What is the Evidence?".对以下内容的回复：致编辑的信，关于文章《秋水仙碱对抗新型冠状病毒感染：证据是什么？》
Rheumatol Ther. 2022 Aug;9(4):1233-1235. doi: 10.1007/s40744-022-00457-6. Epub 2022 May 27.
3
Colchicine in the management of Covid-19: With or lieu of evidence.秋水仙碱在治疗 COVID-19 中的应用：有或无证据支持。
J Pak Med Assoc. 2021 Dec;71(Suppl 8)(12):S127-S132.
4
The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al.秋水仙碱在COVID-19中应用的理论依据：对Cumhur Cure M等人信件的评论
Clin Rheumatol. 2020 Aug;39(8):2489-2490. doi: 10.1007/s10067-020-05232-y. Epub 2020 Jun 20.
5
COVID-19 in patients with gout on colchicine.痛风患者服用秋水仙碱时的新型冠状病毒肺炎
Rheumatol Int. 2021 Aug;41(8):1503-1507. doi: 10.1007/s00296-021-04902-7. Epub 2021 Jun 5.
6
Colchicine in COVID-19: an Old Drug, New Use.秋水仙碱用于治疗新冠肺炎：旧药新用。
Curr Pharmacol Rep. 2020;6(4):137-145. doi: 10.1007/s40495-020-00225-6. Epub 2020 Jul 18.
7
Letter to the Editor Regarding: What Triggers Takotsubo After a SARS-CoV-2 Vaccination? Heart Lung Circ. 2021;30(12):e119-20.致编辑的信：关于接种新型冠状病毒疫苗后是什么引发了应激性心肌病？《心肺循环》。2021年；30(12):e119 - 20。
Heart Lung Circ. 2022 May;31(5):e76-e77. doi: 10.1016/j.hlc.2021.12.010. Epub 2022 Jan 19.
8
Letter #1 Response to letter to Editor by Dr. Sarkar et al. for' who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for' is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?' Refers to PII: S2210-7789(21)00538-9.信件1：对Sarkar博士等人致编辑的信的回复，信的主题为“谁说区分先兆子痫和新冠病毒感染很容易？”，涉及编号：S2210 - 7789(21)00539 - 0
信件2：对Hantoushzadeh博士等人致编辑的信的回复，信的主题为“新冠病毒疾病是先兆子痫的危险因素吗？这些患者是否应考虑使用阿司匹林预防先兆子痫？”，涉及编号：S2210 - 7789(21)00538 - 9
Pregnancy Hypertens. 2022 Mar;27:94-95. doi: 10.1016/j.preghy.2021.11.002. Epub 2021 Nov 25.
9
Letter to the Editor in response to the article 'Candidate drugs against SARS-CoV-2 and COVID-19'.致编辑的信：回应《抗SARS-CoV-2和COVID-19的候选药物》一文
Pharmacol Res. 2021 Jan;163:105285. doi: 10.1016/j.phrs.2020.105285. Epub 2020 Nov 4.
10
[Colchicine: old medication with new benefits : Use in rheumatology and beyond].[秋水仙碱：有新益处的老药物：在风湿病学及其他领域的应用]
Z Rheumatol. 2021 Sep;80(7):647-657. doi: 10.1007/s00393-021-01017-z. Epub 2021 Jun 7.
本文引用的文献
1
Effect of colchicine on mortality in patients with COVID-19 - A systematic review and meta-analysis.秋水仙碱对 COVID-19 患者死亡率的影响——系统评价和荟萃分析。
Diabetes Metab Syndr. 2022 Feb;16(2):102395. doi: 10.1016/j.dsx.2022.102395. Epub 2022 Jan 12.
2
Colchicine-Induced Acute Myopathy: Case Study From Saudi Arabia.秋水仙碱诱发的急性肌病：来自沙特阿拉伯的病例研究
Cureus. 2021 Dec 9;13(12):e20290. doi: 10.7759/cureus.20290. eCollection 2021 Dec.
3
The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID-19: A meta-analysis of randomized trials.秋水仙碱对 COVID-19 患者死亡率和住院时间的影响：随机试验的荟萃分析。
Immun Inflamm Dis. 2022 Feb;10(2):255-264. doi: 10.1002/iid3.562. Epub 2021 Dec 30.
4
A Review of the Rational and Current Evidence on Colchicine for COVID-19.秋水仙碱治疗新冠肺炎的合理性及当前证据综述
Curr Pharm Des. 2022;28(39):3194-3201. doi: 10.2174/1381612827666211210142352.
5
Colchicine for cardiovascular therapy: A drug interaction perspective and a safety meta-analysis.秋水仙碱在心血管治疗中的应用：药物相互作用的视角和安全性荟萃分析。
Anatol J Cardiol. 2021 Nov;25(11):753-761. doi: 10.5152/AnatolJCardiol.2021.707.
6
A systematic review of the infectious complications of colchicine and the use of colchicine to treat infections.系统性综述秋水仙碱感染并发症及秋水仙碱治疗感染的应用。
Semin Arthritis Rheum. 2021 Feb;51(1):101-112. doi: 10.1016/j.semarthrit.2020.11.007. Epub 2020 Dec 17.
7
Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis.连续羟氯喹或秋水仙碱治疗不能预防 SARS-CoV-2 感染：来自大型医疗保健数据库分析的见解。
Autoimmun Rev. 2020 Jul;19(7):102566. doi: 10.1016/j.autrev.2020.102566. Epub 2020 May 5.
Zotero 插件